Insight

$Drew Moghanaki: Single fraction lung SBRT has become my go-to for medically inoperable stage I NSCLC$

Photo from Drew Moghanaki/X

Sep 2, 2024, 08:32

Drew Moghanaki: Single fraction lung SBRT has become my go-to for medically inoperable stage I NSCLC

Drew Moghanaki shared a post on X about a paper by Gregory Videtic et al. published in PubMed.

“Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early-Stage Lung Cancer”

Authors: Gregory Videtic, Chandana Reddy, Neil Woody, Kevin Stephans

$Drew Moghanaki: Single fraction lung SBRT has become my go-to for medically inoperable stage I NSCLC$

“Single fraction lung SBRT has become my go-to for medically inoperable stage I NSCLC. How about others?”

Source: Drew Moghanaki/X

Dr. Drew Moghanaki, a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university.

He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).

cancer Chandana Reddy Drew Moghanaki Gregory Videtic Kevin Stephans Neil Woody non small cell lung cancer NSCLC OncoDaily Oncology Pubmed radiation oncology UCLA

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage